These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29526558)

  • 21. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
    Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
    Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
    He X; Bao W; Li X; Chen Z; Che Q; Wang H; Wan XP
    Int J Mol Med; 2014 Feb; 33(2):325-32. PubMed ID: 24285342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
    He Z; Xu H; Meng Y; Kuang Y
    Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of TRIM44 and its correlation with TLR4 in laryngeal squamous cell carcinoma.
    Bai J; Liu X; Zhang S; Dang S; Zhang Y; Zhang G
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):56-61. PubMed ID: 36227676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer.
    Zhao J; Liu T; Yu G; Wang J
    Tumour Biol; 2015 Feb; 36(2):1299-306. PubMed ID: 25355598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expressions of DAPK3 and c-Myc in endometrial cancer and their relationship with the patients' prognosis].
    Chen C; Guo SQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):863-9. PubMed ID: 27320893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
    Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
    Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
    Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
    Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
    Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
    Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma.
    Meng FL; Yin MZ; Song HT; Yang H; Lou G; Zhou RL
    Int J Gynecol Cancer; 2010 Jul; 20(5):745-50. PubMed ID: 20966643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and clinical significance of MIIP and PAK1 in endometrial carcinoma].
    Jiang S; Tian WY; Yan Y; Teng F; Gao JP; Wang YM; Xue FX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):359-364. PubMed ID: 29860763
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
    Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
    Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma.
    Miyamoto T; Asaka R; Suzuki A; Takatsu A; Kashima H; Shiozawa T
    Exp Mol Pathol; 2011 Oct; 91(2):563-8. PubMed ID: 21763306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of CXCR4/NF-κB Signaling.
    Kou T; Sha D; Wang F; He T; He X
    Cell Biochem Biophys; 2021 Mar; 79(1):113-121. PubMed ID: 33151473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and potential role of SNF5 in endometrial carcinoma.
    Sun S; Wu Y; Zeng K; Zhao Y
    BMC Womens Health; 2019 Jan; 19(1):16. PubMed ID: 30683081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
    Qiu X; Gao Z; Shao J; Li H
    Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.